Haverford Trust Co Invests $230,000 in Verisk Analytics, Inc. (NASDAQ:VRSK)

Haverford Trust Co acquired a new position in shares of Verisk Analytics, Inc. (NASDAQ:VRSK) in the 3rd quarter, Holdings Channel reports. The fund acquired 857 shares of the business services provider’s stock, valued at approximately $230,000.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Legal & General Group Plc increased its stake in Verisk Analytics by 7.4% in the second quarter. Legal & General Group Plc now owns 1,618,266 shares of the business services provider’s stock valued at $436,204,000 after acquiring an additional 111,364 shares during the last quarter. TD Asset Management Inc boosted its position in Verisk Analytics by 5.5% during the second quarter. TD Asset Management Inc now owns 1,502,614 shares of the business services provider’s stock valued at $405,030,000 after buying an additional 78,008 shares during the period. GUARDCAP ASSET MANAGEMENT Ltd lifted its stake in shares of Verisk Analytics by 1.1% in the 1st quarter. GUARDCAP ASSET MANAGEMENT Ltd now owns 1,137,069 shares of the business services provider’s stock valued at $268,041,000 after acquiring an additional 12,231 shares during the last quarter. Dimensional Fund Advisors LP boosted its holdings in Verisk Analytics by 8.4% during the 2nd quarter. Dimensional Fund Advisors LP now owns 1,103,628 shares of the business services provider’s stock valued at $297,491,000 after acquiring an additional 85,202 shares during the period. Finally, Kayne Anderson Rudnick Investment Management LLC grew its position in Verisk Analytics by 6.7% during the 2nd quarter. Kayne Anderson Rudnick Investment Management LLC now owns 613,185 shares of the business services provider’s stock worth $165,284,000 after acquiring an additional 38,258 shares during the last quarter. Hedge funds and other institutional investors own 90.00% of the company’s stock.

Verisk Analytics Stock Performance

Shares of Verisk Analytics stock opened at $286.13 on Friday. The firm has a market capitalization of $40.40 billion, a P/E ratio of 44.64, a P/E/G ratio of 3.64 and a beta of 0.86. The company has a current ratio of 0.82, a quick ratio of 0.82 and a debt-to-equity ratio of 8.36. Verisk Analytics, Inc. has a 12 month low of $217.34 and a 12 month high of $291.42. The business has a fifty day simple moving average of $270.87 and a two-hundred day simple moving average of $265.91.

Verisk Analytics (NASDAQ:VRSK) last released its earnings results on Wednesday, October 30th. The business services provider reported $1.67 EPS for the quarter, topping analysts’ consensus estimates of $1.60 by $0.07. The firm had revenue of $725.30 million for the quarter, compared to analysts’ expectations of $722.19 million. Verisk Analytics had a return on equity of 274.13% and a net margin of 32.65%. The company’s quarterly revenue was up 7.0% on a year-over-year basis. During the same period in the prior year, the firm posted $1.52 earnings per share. On average, equities analysts forecast that Verisk Analytics, Inc. will post 6.63 earnings per share for the current fiscal year.

Verisk Analytics Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, December 31st. Shareholders of record on Friday, December 13th will be paid a dividend of $0.39 per share. The ex-dividend date of this dividend is Friday, December 13th. This represents a $1.56 annualized dividend and a yield of 0.55%. Verisk Analytics’s dividend payout ratio is 24.34%.

Insiders Place Their Bets

In other news, CFO Elizabeth Mann sold 200 shares of the firm’s stock in a transaction dated Tuesday, October 15th. The shares were sold at an average price of $271.33, for a total transaction of $54,266.00. Following the sale, the chief financial officer now owns 15,808 shares of the company’s stock, valued at $4,289,184.64. This trade represents a 1.25 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Corporate insiders own 0.40% of the company’s stock.

Wall Street Analysts Forecast Growth

VRSK has been the subject of a number of recent analyst reports. BMO Capital Markets upped their price target on shares of Verisk Analytics from $263.00 to $276.00 and gave the company a “market perform” rating in a report on Friday, November 1st. Robert W. Baird upped their price target on Verisk Analytics from $285.00 to $301.00 and gave the company an “outperform” rating in a research report on Thursday, October 31st. Evercore ISI reiterated an “in-line” rating and issued a $279.00 price objective on shares of Verisk Analytics in a research report on Wednesday, October 2nd. Barclays upped their target price on Verisk Analytics from $275.00 to $310.00 and gave the company an “overweight” rating in a report on Friday, September 13th. Finally, Wells Fargo & Company upgraded shares of Verisk Analytics to a “strong-buy” rating in a report on Tuesday, August 13th. Six equities research analysts have rated the stock with a hold rating, three have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $285.80.

Verisk Analytics Company Profile

Verisk Analytics, Inc provides data analytics and technology solutions to the insurance markets in the United States and internationally. It offers policy language, prospective loss costs, policy writing and rating rules, and various underwriting solutions for risk selection and segmentation, pricing, and workflow optimization; property- and auto- specific rating and underwriting information solutions that allows clients to understand, quantify, underwrite, mitigate, and avoid potential loss for risks; catastrophe modeling solutions, which enables companies to identify, quantify, and plan for the financial consequences of catastrophes for use by insurers, reinsurers, intermediaries, financial institutions, and governments.